Table 5

Grouped and cognitive AP studies and indicators

Study designCohortCross-sectionalMixed-methodsSecondary cross-sectionalTotal
 N0171624
 %0%71%4%25%100%
Assessment approachesClinical onlySelf-report onlyFunctional onlyClinical and self-reportClinical and functionalOther combinationSecondary sources (multiple)
 N1210101024
 %4%88%0%4%0%4%0%100%
Participants (N)*<500500–9991000–49995000–999910 000–24 999>25 000Not available
 N037554024
 %0%13%29%21%21%17%0%100%
Age (years) included†Under 15<15 to 85+15 to 85+40 to 85+60 to 85+Over 85Other
 N0165020124
 %0%67%21%8%8%0%4%100%
JBI score<778910
 N

02510724
 %0%8%21%42%29%100%
Functioning difficulty or impairment definitionUse of APReported activity limitationsClinical thresholdCombination
 N3210024
 %13%88%0%0%100%
WHO RegionAFRAMREMREURSEARWPRGlobal
 N1471021025
 %56%28%4%0%8%4%0%100%
AP access indicatorTotal needMet needUnmet needUndermet needCoverageUseHas AP
 N2491024242
 %5%10%21%2%0%57%5%100%
Indicator denominatorTotal with/using APTotal with needTotal with functioning difficultyTotal participantsTotal population
 N15288042
 %2%12%67%19%0%100%
  • *Participants (N) ranged from 505 to 393 949 for this domain.

  • †Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.

  • AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.